Telix Pharmaceuticals Limited

TLX ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Jan 13, 2025 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
6-K Dec 30, 2024 CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
S-8 Dec 19, 2024 S-8
SEC STAFF LETTER Nov 21, 2024
6-K Nov 19, 2024 6-K
6-K Nov 14, 2024 6-K
EFFECT Nov 12, 2024
SEC STAFF ACTION Nov 12, 2024
CERT Nov 12, 2024
CORRESP Nov 12, 2024
20FR12B/A Oct 30, 2024 20FR12B/A
SEC STAFF LETTER Oct 28, 2024
F-6 Oct 17, 2024
CORRESP Oct 17, 2024
20FR12B Oct 17, 2024 20FR12B
UPLOAD Oct 10, 2024
DRS Sep 13, 2024
RW Jun 14, 2024 RW
RW Jun 14, 2024 RW
8-A12B Jun 10, 2024 8-A12B
F-1/A Jun 5, 2024 F-1/A
F-6 May 30, 2024
F-1 May 17, 2024 F-1
DRS/A May 9, 2024
DRS/A Apr 15, 2024
← Newer Page 4 of 5 · 103 filings Older →